Results: 53 CYP underwent 57 CE-MRI hip scans: 28% scans showed evidence of inflammation on initial report. Blood test results correlated with scan results in 61%. Scan results informed clinical decision making: 14 CYP changed medication, 10 diagnoses were clarified and 6 CYP received IA steroid injection. Discrepancies were noted between original CE-MRI scan report and second review. Conclusion: CE-MRI scanning is a useful tool for physicians managing JIA and informs clinical decision making; development of a standardized method of CE-MRI scan interpretation including grading of inflammatory changes is desirable.
Introduction: Oxidative stress has been implicated in the pathogenesis of a number of autoimmune diseases including rheumatoid arthritis. The antioxidant superoxide dismutase (SOD) is one of the most important enzymes involved in combating oxidative stress. Aims: To measure SOD activity in JIA patients and to assess whether these levels are influenced by disease activity or JIA subtype. Method: Serum SOD activity was measured in 160 paediatric and adolescent JIA patients and in 16 healthy controls (HC) using a commercial colorimetric assay. Mean age at sampling was 14.05 (1.98-24.48) years for JIA patients and 15.71 (4.50-24.80) for HC. Mean age of JIA onset was 7.02 years (0.14-16.66). Disease activity was defined by presence of swollen joints and an ESR greater or equal to 20 mm/h. Inactive patients were those with no swollen joints and an ESR less than 20 mm/h. Results: SOD activity was shown to be elevated in JIA patients [median ¼ 6.34 U/ml )] compared with controls [median ¼ 3.34 U/ml (IQR 2.15-6.89)] across all subtypes (P ¼ 0.0009). There was no statistically significant difference in SOD activity between subtypes. There was no association between SOD activity and disease activity or drug treatment. However, SOD activity did associate with ANA positivity in patients with JIA [ANA positive: median ¼ 7.46 U/ml (IQR 5.11-9.68)] ANA negative: [median ¼ 5.80 U/ ml (IQR 4.58-7.87)] (P ¼ 0.012). Conclusion: Elevated activity of the antioxidant SOD may be a response to increased oxidative stress in JIA. However, it does not seem to represent a useful biomarker of disease activity. Disclosure statement: The authors have declared no conflicts of interest. Introduction: Damage via generation of free radicals has been implicated in the pathogenesis of SLE. Antioxidants such as superoxide dismutase (SOD) function to protect against oxidative damage and levels are typically elevated in situations of high oxidative stress. Aims: Quantify the activity of the antioxidant enzyme SOD in adolescent patients with juvenile onset SLE (JSLE). Method: Serum was obtained from 49 patients with JSLE, 160 JIA disease controls, and 16 healthy adolescent controls (HC) (mean age at sampling 18.95 (13.57-24.18), 14.05 (1.98-24.48) and 15.71 (4.50-24.80 ) years respectively). SOD activity was measured using a commercial colorimetric assay. Results: Surprisingly, no statistically significant difference in SOD activity was observed between JSLE [median ¼ 4.04 U/ml (IQR 2.79-8.06)] and HC [median ¼ 3.34 U/ml (IQR 2.15-6.89)] though SOD activity was raised in patients with JIA [median ¼ 6.34 U/ml )] compared with controls and JSLE (P ¼ 0.0009 and 
ABSTRACT 41 BSPAR150 ANTIOXIDANT SUPEROXIDE DISMUTASE ACTIVITY IS PARADOXICALLY NORMAL IN JUVENILE SYSTEMIC LUPUS ERYTHEMATOSUS

